Company Profile: Colgate-Palmolive Company (CL)

CL insider trades (13 months) →

$95.62 −1.86% vs. previous close · Market cap $76.01B

Today's multi-factor rank: 323 of 461 · see the ranking

Quant500 Scores

Momentum

5.3/10

Value

3.9/10

Growth

4.2/10

Quality

5.3/10

Multifactor

4.7/10

Market and Valuation

Price & Market

Prev Close Price:$97.43

Open:$96.76

Day's Low:$95.25

Day's High:$96.90

Bid / Ask:-

Market Cap:76.01B

Enterprise Value:83.91B

52-Week Range

52-Week Low:$75.00

52-Week High:$99.33

Current position in 52-week range

52w Low-52w High

50-Day Avg:$89.68

200-Day Avg:$89.75

Volume

Volume Today:5,138,337

Avg Volume (3m):4,824,726

Avg Volume (10d):5,023,410

52-Week Change:+27.28%

vs S&P 500, 52 weeks:-

Beta:0.31

Valuation Multiples

P/E (trailing):37.35

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

P/E (forward):23.32

PEG Ratio:1.78

Price / Book:264.14

Price / Sales (TTM):3.57

EV / Revenue:3.94

EV / EBITDA:16.65

Dividends

Current yield:2.18%

Annual Dividend Rate:$2.12

Dividend Trailing:$2.10

Yield Trailing:2.16%

5-Year Avg Yield:2.31%

Payout Ratio:81.71%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):21.28B

Gross Profit:12.91B

EBITDA:5.04B

Net Income (TTM):2.05B

Rev Growth (YoY):+4.60%

Earnings Growth (YoY):+3.30%

Quarterly earnings growth (YoY):+2.20%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):$2.56

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$4.10

Revenue Per Share:$26.58

Cash Per Share:-

Book Value:$0.36

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:1.61B

Total Debt:7.72B

Net Debt (Debt - Cash):6.10B

Debt / Equity:1,205.63%

Current Ratio:0.96

Quick Ratio:0.53

Cash Flows

Operating Cash Flow:4.37B

Free Cash Flow (FCF):3.37B

FCF Yield (FCF / Market Cap):-

Enterprise Value:83.91B

EV / Revenue:3.94

EV / EBITDA:16.65

Profitability

ROE (Return on Equity):231.74%

ROA (Return on Assets):16.05%

P/E (trailing):37.35

P/E (forward):23.32

Price / Book:264.14

PEG Ratio:1.78

52-Week Change:+27.28%

S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$2.56

Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$4.10

P/E (forward):23.32

PEG Ratio:1.78

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$26.58

Cash Per Share:-

Book Value:$0.36

Cash Flows (TTM)

Free Cash Flow:3.37B

Operating Cash Flow:4.37B

EBITDA:5.04B

Total Revenue (TTM):21.28B

Net Income (TTM):2.05B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:794,920,513

Float (free shares):746,239,581

Short interest (shares):17,408,859

Short % of float:-

Short Ratio (days to cover):3.19

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Colgate-Palmolive Company (CL) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
8-K	2026-10-30	View filing ↗
10-Q	2026-07-31	View filing ↗
11-K	2026-06-24	View filing ↗
SD	2026-06-01	View filing ↗
8-K	2026-05-13	View filing ↗
8-K	2026-05-01	View filing ↗
DEFA14A	2026-04-16	View filing ↗
8-K	2026-04-09	View filing ↗
DEFA14A	2026-03-25	View filing ↗
8-K	2026-03-17	View filing ↗

Company and Executive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

General Information

Headquarters:United States

City:New York

Employees:33,600

Sector:Consumer Defensive

Industry:Household & Personal Products

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Noel R. Wallace	Chairman, CEO & President	61	4.84M
Mr. Stanley J. Sutula III	Chief Financial Officer	59	2.54M
Mr. Panagiotis Tsourapas	COO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health	60	2.16M
Mr. Shane Grant	Chief Operating Officer of Americas	50	3.06M
Mr. Stephan Habif	Chief Technology Officer	-	-
Mr. David Foster	Chief Information Officer	-	-
Ms. Betsy Fishbone	EVP, Chief Legal Officer & Secretary	-	-
Mr. Eutychus Karuru	Executive Vice President of Internal Audit & Compliance	-	-

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Colgate-Palmolive Company (CL): Quantitative Analysis

Name: Factor scores for Colgate-Palmolive Company (CL)
Creator: Quant500
License: https://quant500.com/legal

Colgate-Palmolive Company (CL) — Consumer Defensive — Household & Personal Products. CL is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, CL has returned +23.7% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

CL ranks 323 of 461 on today's multifactor score, and 18 of the 30 Consumer Defensive companies that score. Its strongest factor is momentum (Z 0.20, ranked 181 of 494); its weakest is value (Z -0.67, ranked 442 of 489). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.202	323 of 461
Momentum	0.196	181 of 494 ↑10
Value	-0.672	442 of 489 ↑1
Quality	0.163	150 of 468 ↓1
Growth	-0.495	417 of 489

Market data

Metric	Value
Price	$95.62
Market Cap	76.01B
P/E	37.35
Revenue (last 12 months)	21.28B
Price / book	264.14
Book value per share	$0.36
52-week range	$75.00 – $99.33
Dividend yield	2.18%
Beta	0.31
Average volume	4,824,726
Shares outstanding	794.92M
Short interest (% of float)	2.45% (as of Oct 15, 2026)

When does CL report earnings? 10 of its last 10, before the open →

What are CL insiders doing? 125 transactions filed with the SEC, of them 15 sells, the last one on Oct 1, 2026 →

CL latest SEC filings

Annual report (10-K): filed Feb 23, 2026, fiscal year ended Dec 31, 2025 · view the filing on sec.gov
Quarterly report (10-Q): filed Oct 30, 2026, quarter ended Sep 30, 2026 · see its 10-Q filings on sec.gov
Earnings release (8-K): Oct 30, 2026, before the open · view the 8-K on sec.gov

Filing dates on EDGAR, the SEC's public registry. All CL filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Colgate-Palmolive (CL)

When does Colgate-Palmolive report earnings?

Colgate-Palmolive has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 10 before the open (and 2 with no time on the filing) (SEC filings through Oct 30, 2026). CL earnings dates and times, quarter by quarter →

What is Colgate-Palmolive's P/E ratio?

Colgate-Palmolive's P/E (price over earnings per share for the last twelve months) is 37.4 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 30, 2026. The median of the 30 Consumer Defensive companies with a P/E is 21.2, and the S&P 500's, 23.5: Colgate-Palmolive is above its sector median. Consumer Defensive stocks, company by company →

Where does Colgate-Palmolive rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Colgate-Palmolive ranks 323 of 461, and 18 of the 30 Consumer Defensive companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Colgate-Palmolive insiders bought or sold shares?

SEC Form 4 shows no open-market purchase of Colgate-Palmolive shares from August 2025 through Nov 3, 2026. The latest sale was on Aug 24, 2026, by an officer, for $920k. In total, from August 2025 through Nov 3, 2026: 0 purchases and 15 sales by directors, officers and large shareholders. All CL insider trades →

Does Colgate-Palmolive pay a dividend?

Yes. Its dividend yield is 2.18% at the Nov 3, 2026 close (annual dividend of $2.12 per share). The latest recorded ex-dividend date is Oct 20, 2026.

What sector is Colgate-Palmolive in, and which index?

Colgate-Palmolive is classified in the Consumer Defensive sector (industry: Household & Personal Products), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 33 S&P 500 companies in that sector. Consumer Defensive stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

Valuation multiples: P/E, P/B, EV/EBITDA and their trapsWhy the P/E and the price-to-book in the table above cannot be compared across sectors, and what a low P/E can hide.
Value and momentum: the two that have survived bestWhat the value and momentum scores on this page actually measure, and why they are the two factors that have best survived scrutiny.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
Sales growth: the driver that gets overestimated mostWhat sits behind the growth score and the twelve-month revenue, and why it is the number people extrapolate too far most often.
Dividends and payout: high is not always goodThis company pays a dividend and its yield is in the table above: when a high figure is good news and when it is a warning.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile: Colgate-Palmolive Company (CL)

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Colgate-Palmolive Company (CL) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Colgate-Palmolive Company (CL): Quantitative Analysis

Factor scores

Market data

CL latest SEC filings

Frequently asked questions about Colgate-Palmolive (CL)

When does Colgate-Palmolive report earnings?

What is Colgate-Palmolive's P/E ratio?

Where does Colgate-Palmolive rank on Quant500?

Have Colgate-Palmolive insiders bought or sold shares?

Does Colgate-Palmolive pay a dividend?

What sector is Colgate-Palmolive in, and which index?

What is behind these numbers